Investor Relations

Welcome to the Investor Relations section of the MediSys Corporation website. In these pages, you will find the answers to frequently asked questions, our corporate brochure, links to our latest press releases, an events calendar, and information request forms. If you have any questions or suggestions for improving the Investor Relations section, please contact us at the email or phone number below.

Corporate Profile

MediSys Corporation provides medical technology solutions to physicians in the internal medicine, family practice and general practice markets by offering innovative practice enhancement tools in the form of unique systems or modules. These easily integrated cost-effective modules enable doctors to provide superior medicine while significantly improving revenues and profits by leveraging their existing practice infrastructure.

Each of these systems is also a practice enhancement/revenue enhancement tool for the financially distressed Primary Care Physician (PCP). Company research has uncovered several trends in PCP practice profitability. Increased operating costs and diminished reimbursement have lead to a financial crisis for these physicians. If these trends continue, and there is no reason to believe that they won’t, the average PCP in the US will soon be earning less then $84,000 per year. The graph below demonstrates the trend of the eroding practice income for the PCP.

The MediSys mission is to provide medical facilities with practice enhancement tools along with the training, support and marketing to properly implement them.

Source: MGMA & Medical Economics.

When properly implemented these tools enable the physician to not only practice better medicine but proactively reverse the negative trends exhibited above.

The Company’s initial product is a cost-effective “patient acquisition” tool that utilizes an innovative disease identification and management system that will allow the physician to better serve their male patients and enhance the practice. It is analogous to a women’s health center, except the focus is on men’s health. The physician will be able to identify and manage a myriad of serious diseases prevalent in men earlier in the disease process and we all know early detection is the key to effective treatment and a cure. Diseases such as: coronary artery disease, vascular disease, diabetes, hypertension, prostate and other urologic cancers, BPH, and approximately 25 lesser known disorders can be identified 12-18 months earlier utilizing the Company’s system.

Corporate Headquarters

Corporate Offices:
800 Village Square Crossing
Suite 201
Palm Beach Gardens, FL 33410

Contact Information:
Tel: 561-622-5889
Fax: 561-656-2099
e-mail: info@medisyscorp.com

Investor Information:
Tel: 561-622-1255
e-mail: ir@medisyscorp.com

Shareholder Information:

Exchange:
Pink Sheets

Listed Security:
MDYO-Common Stock
CUSIP #58500E201